Published

Trial finds psilocybin improves symptoms in treatment-resistant depression

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: The Brown University Psychopharmacology Update
Date: 2025-04-28
Source: OpenAlex
DOI: 10.1002/pu.31317
PubMed: Unavailable

Authors

Watch author

Topics and keywords

psilocybin Depression Treatment-Resistant Depression Other Psilocybin Depression (economics)Medicine Psychology Hallucinogen Psychiatry Keynesian economics Economics Psychedelics and Drug Studies Mental Health and Psychiatry Digital Mental Health Interventions

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Trial finds psilocybin improves symptoms in treatment-resistant depression2025-04-28

Related papers

The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up studyNeuroscience Applied · 2022-12-31 Psilocybin may be effective for treatment-resistant depressionPharmaceutical journal/The pharmaceutical journal · 2021-12-31 The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant DepressionEmerging Minds Journal for Student Research · 2026-01-24 Psilocybin Treatment for Refractory Depression: A Clinical ReviewDigital Commons - Gardner-Webb University (Gardner-Webb University) · 2025-12-31 Compassionate use of psilocybin for treatment-resistant depression in GermanyThe Lancet Psychiatry · 2025-09-22 194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-08 166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-08 An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United StatesPsychedelics. · 2024-09-12